Posted: July 9, 2023 | Healthcare IT Today Providers spend 11% less time writing clinical notes than they did three years ago, 54% of surgeons unsure about first-to-market products, and more
Posted: July 7, 2023 | Drug Discovery & Development Leqembi could mark new era in Alzheimer’s treatment progress: An overview of the evolving drug development scene
Posted: July 6, 2023 | BioWorld Biogen, Eisai’s Leqembi gains full approval from FDA; sales upsurge near?
Posted: July 6, 2023 | MM&M FDA grants Leqembi full approval in watershed moment for Alzheimer’s care
Posted: June 16, 2023 | FiercePharma US oncologists see cost as biggest barrier to new cancer drug uptake, with cell, gene therapy expertise lagging: survey
Posted: May 1, 2023 | Medical Marketing & Media The good, the bad and the ugly of TikTok’s dermatology trends
Posted: April 28, 2023 | Healthcare Marketer's Exchange A Personal Story That Led to Global Medical Research Advancement
Posted: April 14, 2023 | McKnights Senior Living Robots could be good investment to mitigate loneliness among residents
Posted: April 12, 2023 | PharmExec The Ascendancy of Social Media: Fitting Pharma Brand Teams Into the Conversation Mix
